Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Evolution of Macrophage Function in Sepsis-Induced Cardiomyopathy: Cellular Networks from Immune Imbalance to Myocardial Injury.

Created on 29 Sep 2026

Authors

Wenye Xu, Xianwen Wang, Jinwei Dai, Guotao Wang, Xueyao Yang, Qianbing Wang, Xuexuan Li, Qihang Huang, Yuxin Li, Lina Zhang, Zhihong Zuo, Zhaoxin Qian

Published in

Pharmacological research. Pages 108475. Sep 28, 2026. Epub Sep 28, 2026.

Abstract

Sepsis-induced cardiomyopathy (SICM) is an acute, often reversible myocardial depression driven by the host response to infection. Cardiac macrophages are central signaling hubs that integrate systemic danger signals and orchestrate myocardial dysfunction. We introduce a "Macrophage Functional Continuum" model, conceptualizing macrophages as dynamic signal integrators undergoing three interconnected phases: sensing and initiation, intrinsic reprogramming and fate determination, and multicellular network execution. Conceptually, these phases represent functional modules that may overlap in time and vary across organs, rather than a rigid chronological sequence. Stage-matched strategies-including immunometabolic modulation, checkpoint control, nanomedicine, and macrophage-based therapies-may provide a more context-sensitive therapeutic framework than conventional anti-inflammatory approaches. This review aims to reframe macrophage biology in SICM and provide a roadmap for translational research.

PMID:
42805519
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement